Defence is the Best Attack : Immuno-Oncology Breakthroughs 2017
- Medical_Professionals
- Medical_students
- Nurses
We are living in very exciting times in the context of molecular oncology and in particular in the field of immuno-oncology. A deeper understanding of the molecular mechanisms involved in the interaction between the tumour and the immune system is revealing an attractive set of novel therapeutic approaches to treat cancer. With some pronounced recent successes in this field, this is fuelling aggressive investigation, leading to new questions and challenges.
In this conference, we will learn about the most recent advances in the field of immunotherapy from the basic science to clinical studies including the identification of novel targets; an improved understanding of the mechanisms of action of therapeutic interventions; as well as discussions about biomarkers of response to treatment and mechanisms of intrinsic and acquired resistance to immunotherapy.
Target audience
The target audience for this conference is basic and translational scientists and clinicians, both senior and young investigators that want to have a broad and detailed overview of the most recent advances in the field of immunotherapy.
Topics to be covered
Immune checkpoints
Immunoediting
Innate immune response
Microbioma and the immune system
CAR T cells
Vaccination
Biomarkers of response to immunotherapy
Mechanisms of resistance to immunotherapy
Scientific Programme Committee: Johanna Joyce, Ignacio Melero, Daniel Peeper, Joan Seoane (Chair)
George Coukos
George Coukos
University of Lausanne, Switzerland
Lisa Coussens
Lisa Coussens
OHSU, Knight Cancer Institute, USA
Karin de Visser
Karin de Visser
NKI, Netherlands
Alena Gros
Alena Gros
VHIO, Spain
Johanna Joyce
Johanna Joyce
University of Lausanne, Switzerland
Carl June
Carl June
University of Pennsylvania, USA
Guido Kroemer
Guido Kroemer
Cordelier Research Centre, France
Miguel López-Botet
Miguel López-Botet
Hospital de Mar Medical Research Institute (IMIM), Spain
Ignacio Melero
Ignacio Melero
Clinical University of Navarra, Spain
Daniel Peeper
Daniel Peeper
NKI, Netherlands
Sergio Quezada
Sergio Quezada
UCL Cancer Institute, UK
Joan Seoane
Joan Seoane
VHIO, Spain
Kris Thielemans
Kris Thielemans
ORC, Belgium
Zlatko Trajanoski
Zlatko Trajanoski
Medical University of Innsbruck, Austria
Pablo Umaña
Pablo Umaña
Roche Innovation Center Zurich, Switzerland
Jedd Wolchok
Jedd Wolchok
MSKCC, USA
Laurence Zitvogel
Laurence Zitvogel
Institut Gustave Roussy, France
EUR
2017-08-03
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
La Pedrera / Casa Mila
Provenca, 261-265
Barcelona, Cataluna, Spain
Submission Info
Five proffered papers will be selected from submitted abstracts for oral presentation. All abstracts will be reviewed by the Scientific Programme Committee and successful participants will be notified of their poster or oral presentation as soon as possible after evaluation.
EACR Poster Prizes
Two EACR Poster Prizes of €100 each will be awarded for the best posters as selected by the judges.
Abstract submission deadline: 31 July 2017
Abstracts must be submitted online. You can edit your abstract(s) until the abstract submission deadline shown above. The main abstract text is limited to 300 words but this does not include the information relating to title, author and affiliation.
Contact No.: +44 (0)11595 15065
Email: eacr@nottingham.ac.uk
Contact No.: +44 (0)11595 15065
Email: eacr@nottingham.ac.uk